• Image of Opzelura medication Image of Opzelura medication
    • OPZELURA

    • QTY 60
    • 1.5 %
    • Cream (g)
    • Near  77381

RUXOLITINIB (RUX oh LI ti nib) treats eczema. It may also be used to treat a condition that causes loss of skin color in patches (vitiligo). It works by slowing down an overactive immune system.


OPZELURA Lifestyle Interactions

  • Ruxolitinib 1.5%, Topical cream

    Interaction: Grapefruit juice
    Severity: Major
    Notes for Consumers: Do not drink grapefruit juice or eat grapefruit or grapefruit-containing foods while taking Ruxolitinib. Side effects from Ruxolitinib may get worse. Contact your prescriber immediately if you experience any new or unusual side effects.
    Notes for Professionals: Advise patients to avoid grapefruit and grapefruit juice during ruxolitinib treatment due to the risk of increased ruxolitinib exposure and adverse reactions. Ruxolitinib is a CYP3A substrate and grapefruit juice is a strong CYP3A inhibitor.

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.